65 related articles for article (PubMed ID: 6228456)
1. Correlation between immunogenetic markers and "in vivo" response to the german hepatitis B vaccine.
Höher PG; Vögeler U; Schröder G; Werner J; Doxiadis I; Grosse-Wilde H
Dev Biol Stand; 1983; 54():171-8. PubMed ID: 6228456
[TBL] [Abstract][Full Text] [Related]
2. Association of HLA phenotype with primary non-response to recombinant hepatitis B vaccine: a study from north India.
Das K; Gupta RK; Kumar V; Singh S; Kar P
Trop Gastroenterol; 2004; 25(3):113-5. PubMed ID: 15682656
[TBL] [Abstract][Full Text] [Related]
3. [HLA typing and insulin antibody production in insulin-dependent diabetics].
Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
[TBL] [Abstract][Full Text] [Related]
4. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
5. Kinetics, subtype specificity and immunoglobulin class of anti-HBs induced by hepatitis B vaccine.
Legler K; Strohmeyer H; Ritter S; Gerlich WH; Thomssen R
Dev Biol Stand; 1983; 54():179-89. PubMed ID: 6228457
[TBL] [Abstract][Full Text] [Related]
6. Active hepatitis B immunization with an experimental German vaccine. I. Immunogenicity studies in healthy adults. II. The primary 19 S and 7 S responses to HBsAg in healthy adults. III. Immunogenicity studies in hemodialysis patients.
Scheiermann N; Kuwert EK
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):439-55. PubMed ID: 6485639
[TBL] [Abstract][Full Text] [Related]
7. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C.
Wiedmann M; Liebert UG; Oesen U; Porst H; Wiese M; Schroeder S; Halm U; Mössner J; Berr F
Hepatology; 2000 Jan; 31(1):230-4. PubMed ID: 10613751
[TBL] [Abstract][Full Text] [Related]
8. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
[TBL] [Abstract][Full Text] [Related]
9. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
[TBL] [Abstract][Full Text] [Related]
10. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen.
Caillat-Zucman S; Gimenez JJ; Wambergue F; Albouze G; Lebkiri B; Naret C; Moynot A; Jungers P; Bach JF
Kidney Int; 1998 Jun; 53(6):1626-30. PubMed ID: 9607193
[TBL] [Abstract][Full Text] [Related]
11. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen.
Huang LM; Chiang BL; Lee CY; Lee PI; Chi WK; Chang MH
Hepatology; 1999 Mar; 29(3):954-9. PubMed ID: 10051503
[TBL] [Abstract][Full Text] [Related]
12. [Study on the immuno-effects of recombinant hepatitis B vaccination in adults].
Zhang FM; Zhao QX; Han JH; Zhou QH; Wang MC; Miao W; Li R
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Aug; 24(8):697-9. PubMed ID: 14521791
[TBL] [Abstract][Full Text] [Related]
13. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells.
Krishnamurthy G; Kher V; Naik S
Scand J Urol Nephrol; 2002; 36(5):377-82. PubMed ID: 12487744
[TBL] [Abstract][Full Text] [Related]
14. HLA antigens and the antibody response after vaccination to hepatitis B.
Matej H; Nowakowska B; Pacyńska J; Gładysz A; Zalewska M; Simon K
Arch Immunol Ther Exp (Warsz); 1988; 36(4):505-9. PubMed ID: 3074745
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B vaccine: safety study in anti-HBs seronegative human volunteers.
Kaufmann R; Mondorf AW; Uthemann H; Bauer H; Prince AM
Dev Biol Stand; 1983; 54():229-35. PubMed ID: 6228463
[TBL] [Abstract][Full Text] [Related]
16. Preliminary results of immune response to hepatitis B (HB) vaccine (Pasteur) in adults.
Giunchi G; Panichi G; Pescini A; Pezzella M; Galli C; Chircu LV; Sorice F
Dev Biol Stand; 1983; 54():153-9. PubMed ID: 6228454
[TBL] [Abstract][Full Text] [Related]
17. HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination.
Lin HH; Liao HW; Lin SK; Wang LY
Vaccine; 2008 Jun; 26(27-28):3414-20. PubMed ID: 18501999
[TBL] [Abstract][Full Text] [Related]
18. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
Jafarzadeh A; Zarei S; Shokri F
Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of heat-inactivated hepatitis B vaccine (CLB) in low risk human volunteers and in patients treated with chronic haemodialysis in the Netherlands.
Reerink-Brongers EE; Lelie PN; Reesink HW; Dees PJ; Brummelhuis HG; van Aken WG
Dev Biol Stand; 1983; 54():197-203. PubMed ID: 6228459
[TBL] [Abstract][Full Text] [Related]
20. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN
Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
